Disease modeling and target identification are critical and time-consuming portions of the drug discovery process and areas where artificial intelligence (AI) is already making a substantial impact. A ...
When Insilico Medicine’s CEO Alex Zhavoronkov, PhD, and his co-authors wrote their 2023 opinion paper on AI-powered target discovery, 1 he was thinking about how often target discovery is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback